Literature DB >> 18844762

Resistant arterial hypertension is associated with higher blood levels of complement C3 and C-reactive protein.

Eli Magen1, Joseph Mishal, Jana Paskin, Zahava Glick, Chaim Yosefy, Mona Kidon, Menachem Schlesinger.   

Abstract

Arterial hypertension is associated with increased plasma levels of complement C3, C4, and C-reactive protein (CRP). The aim of the study was to compare these laboratory markers in patients with resistant arterial hypertension (RAH) and controlled arterial hypertension (CAH). Patients with RAH (n = 34), those with CAH (n = 34), and 26 normotensive controls were included. White blood cell count, erythrocyte sedimentation rates, and blood levels of complement components C3, C4, and high-sensitivity C-reactive protein (hs-CRP) were compared among the study groups. In the RAH group, serum C3 (183.9+/-47.5 mg/dL) and hs-CRP (6.9+/-5.8 mg/L) were higher than in the CAH group (C3, 123.1+/-42.3 mg/dL; P < .001, hs-CRP, 4.2+/-4.8; P = .021, respectively). Significant positive correlations between systolic blood pressure and C3 (r = 0.6481; P < .001) and hs-CRP (r = 0.3968; P = .02) were observed in the RAH group. RAH is associated with higher blood levels of C3 and CRP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18844762      PMCID: PMC8673401          DOI: 10.1111/j.1751-7176.2008.00002.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  34 in total

Review 1.  Clinical practice. Resistant or difficult-to-control hypertension.

Authors:  Marvin Moser; John F Setaro
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

2.  Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes.

Authors:  J Kulics; H R Colten; D H Perlmutter
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

3.  Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro.

Authors:  A Ueki; T Sai; H Oka; M Tabata; K Hosokawa; Y Mochizuki
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

4.  Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

Authors:  Thang S Han; Naveed Sattar; Ken Williams; Clicerio Gonzalez-Villalpando; Michael E J Lean; Steven M Haffner
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control.

Authors:  Eli Magen; Reuven Viskoper; Joseph Mishal; Rita Priluk; Arkadi Berezovsky; Anni Laszt; Daniel London; Chaim Yosefy
Journal:  Isr Med Assoc J       Date:  2004-12       Impact factor: 0.892

7.  Production of the third and fourth component of complement (C3, C4) by smooth muscle cells.

Authors:  Y Ueda; K Nagasawa; H Tsukamoto; T Horiuchi; H Nishizaka; K Ikeda; Y Niho
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

8.  Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ivan Yuhanna; Philip Shaul; Ishwarlal Jialal
Journal:  Circulation       Date:  2002-09-17       Impact factor: 29.690

9.  Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

10.  Relation of left ventricular hypertrophy with systemic inflammation and endothelial damage in resistant hypertension.

Authors:  Gil F Salles; Roberto Fiszman; Claudia R L Cardoso; Elizabeth S Muxfeldt
Journal:  Hypertension       Date:  2007-07-16       Impact factor: 10.190

View more
  15 in total

Review 1.  Inflammation in Hypertension.

Authors:  Liang Xiao; David G Harrison
Journal:  Can J Cardiol       Date:  2020-01-24       Impact factor: 5.223

Review 2.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

3.  The potential role of complement alternative pathway activation in hypertensive renal damage.

Authors:  Chongjian Wang; Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

4.  Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication.

Authors:  Michael I Koukourakis; Georgia Kambouromiti; Dimitra Pitsiava; Pelagia Tsousou; Maria Tsiarkatsi; George Kartalis
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

5.  Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.

Authors:  Matija Crnogorac; Ivica Horvatic; Patricia Kacinari; Danica Galesic Ljubanovic; Kresimir Galesic
Journal:  J Nephrol       Date:  2017-10-13       Impact factor: 3.902

6.  The relationship between neutrophil to lymphocyte ratio and artery stiffness in subtypes of hypertension.

Authors:  Huan Wang; Yuanhui Hu; Yanting Geng; Huaqin Wu; Yuguang Chu; Ruihua Liu; Yi Wei; Zhiling Qiu
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-05-07       Impact factor: 3.738

7.  Increased Neutrophil to Lymphocyte Ratio in Patients With Resistant Hypertension.

Authors:  Erdal Belen; Aylin Sungur; Mustafa Azmi Sungur; Güney Erdoğan
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-23       Impact factor: 3.738

8.  The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis.

Authors:  Mehdi Mirsaeidi; Hesham R Omar; Golnaz Ebrahimi; Micheal Campos
Journal:  Int J Hypertens       Date:  2016-06-28       Impact factor: 2.420

9.  Correlation between neutrophil-to-lymphocyte ratio and kidney dysfunction in undiagnosed hypertensive population from general health checkup.

Authors:  Chen Chen; Hai Yan Zhao; Yin Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-01       Impact factor: 3.738

10.  Associations of CFH polymorphisms and CFHR1-CFHR3 deletion with blood pressure and hypertension in Chinese population.

Authors:  Wei Gan; Johnna Wu; Ling Lu; Xu Xiao; Heng Huang; Fulong Wang; Jingwen Zhu; Liang Sun; Gang Liu; Yi Pan; Huaixing Li; Xu Lin; Yan Chen
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.